PER percheron therapeutics limited

Prof Thomas Voit, DMD expert, interview with Wilsons advisory, page-7

  1. 14,717 Posts.
    lightbulb Created with Sketch. 1588
    Acco

    rding to the studies that have been done on ATL1102, we can supposedly expect results that are just as good (if not better) than Tysabri and possibly without the potential side effects like PML or some of the possible long term side effects of other MS medications. That is a pretty large claim if you ask me but I am definitely interested! On top of that, this medication is plannedto be self administered by injections rather than IV which some may feel is more convenient than having to drive in to an infusion center once a month.

    Akki: your a bad bad boy!! Worse than Markie..
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.8¢
Change
-0.001(5.88%)
Mkt cap ! $8.699M
Open High Low Value Volume
0.9¢ 0.9¢ 0.8¢ $16.64K 2.010M

Buyers (Bids)

No. Vol. Price($)
24 6525662 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 1987416 4
View Market Depth
Last trade - 15.25pm 18/07/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.